Sanofi
SNY
$42.78
$0.100.23%
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 17.82% | 12.21% | |
| Total Other Revenue | -- | -- | -10.43% | -9.33% | |
| Total Revenue | -- | -- | 15.33% | 10.40% | |
| Cost of Revenue | -- | -- | 6.50% | 2.12% | |
| Gross Profit | -- | -- | 19.30% | 14.19% | |
| SG&A Expenses | -- | -- | 15.74% | 7.13% | |
| Depreciation & Amortization | -- | -- | -9.03% | -15.24% | |
| Other Operating Expenses | -- | -- | 12.10% | -1.32% | |
| Total Operating Expenses | -- | -- | 10.63% | 3.77% | |
| Operating Income | -- | -- | 37.82% | 44.47% | |
| Income Before Tax | -- | -- | 82.69% | 62.80% | |
| Income Tax Expenses | -- | -- | 130.70% | 135.52% | |
| Earnings from Continuing Operations | -- | -- | 74.07% | 51.03% | |
| Earnings from Discontinued Operations | -- | -- | 1,326.51% | -55.27% | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -142.65% | -84.47% | |
| Net Income | -- | -- | 120.10% | 35.77% | |
| EBIT | -- | -- | 37.82% | 44.47% | |
| EBITDA | -- | -- | 30.32% | 32.11% | |
| EPS Basic | -- | -- | 123.53% | 36.33% | |
| Normalized Basic EPS | -- | -- | -- | -- | |
| EPS Diluted | -- | -- | 123.83% | 36.25% | |
| Normalized Diluted EPS | -- | -- | -- | -- | |
| Average Basic Shares Outstanding | -- | -- | -0.95% | -0.33% | |
| Average Diluted Shares Outstanding | -- | -- | -1.04% | -0.24% | |
| Dividend Per Share | -- | -- | 3.23% | 3.23% | |
| Payout Ratio | -- | -- | -- | -- | |